Phibro Animal Health (PAHC) EPS (Basic) (2012 - 2026)

Phibro Animal Health's EPS (Basic) history runs 15 years deep, the most recent figure standing at $0.59 for Q1 2026.

• On a quarterly basis, EPS (Basic) rose 14.97% year-over-year to $0.59 in Q1 2026; TTM through Mar 2026 was $2.35, a 782.7% increase from a year earlier, with the FY2025 full-year figure at $1.19, up 211.4% from the prior year.
• EPS (Basic) declined to $0.59 in Q1 2026 per PAHC's latest filing, from $0.68 in the prior quarter.
• Across five years, EPS (Basic) topped out at $0.68 in Q4 2025 and bottomed at -$1.11 in Q2 2024.
• The 5-year median for EPS (Basic) is $0.21 (2024), against an average of $0.2.
• Across the five-year window, EPS (Basic) tumbled 491.19% in 2024 and soared 761.5% in 2025, its largest moves.
• Year by year, EPS (Basic) stood at $0.18 in 2022, then sank by 82.33% to $0.03 in 2023, then jumped by 150.0% to $0.08 in 2024, then soared by 761.5% to $0.68 in 2025, then slipped by 12.55% to $0.59 in 2026.
• Per Business Quant, the three latest PAHC EPS (Basic) figures stand at $0.59 (Q1 2026), $0.68 (Q4 2025), and $0.65 (Q3 2025).